Master Clinical Problem Solving (CPS) - CVS
for MSRA

What the MSRA Tests in Clinical Problem Solving (CPS) - CVS

Clinical Problem Solving (CPS) - CVS on the MSRA tests your ability to manage common cardiovascular presentations in primary and emergency care. You must demonstrate safe, guideline-based decision-making: selecting appropriate first-line investigations (e.g., ECG, troponin, NT-proBNP, echocardiography), initiating evidence-based treatments (e.g., dual antiplatelet therapy in NSTEMI, ACE inhibitors in heart failure with reduced ejection fraction), and recognising when to refer or admit. The exam emphasises acute presentations (chest pain, breathlessness, palpitations, syncope, hypotension) and chronic conditions (heart failure, hypertension, atrial fibrillation, stable angina). You are expected to apply NICE and ESC guidelines, interpret basic ECGs and blood results, and avoid management errors such as giving beta-blockers in acute decompensated HF or missing red flags like aortic dissection or cardiac tamponade.

High-Yield Concepts

• Acute Coronary Syndrome (ACS) – Management: For STEMI: immediate primary PCI (within 120 min) or fibrinolysis if >120 min delay. Dual antiplatelet therapy (aspirin 300 mg + ticagrelor 180 mg or prasugrel 60 mg). For NSTEMI: risk stratify using GRACE score; if >140, urgent angiography within 24 hours. Start fondaparinux 2.5 mg SC once daily unless high bleeding risk.
• Heart Failure – Classification and Treatment: Use NYHA class and LVEF. HFrEF (LVEF ≤40%): first-line ACE inhibitor (e.g., ramipril 2.5 mg BD) + beta-blocker (bisoprolol 1.25 mg OD) + MRA (eplerenone 25 mg OD) if persistent symptoms. Add SGLT2 inhibitor (dapagliflozin 10 mg OD). For acute decompensated HF with pulmonary oedema: IV furosemide 40-80 mg, consider non-invasive ventilation.
• Atrial Fibrillation – Rate vs Rhythm Control and Anticoagulation: Rate control first-line: beta-blocker (e.g., bisoprolol) or rate-limiting calcium channel blocker (diltiazem). Rhythm control (e.g., amiodarone, flecainide) if symptomatic despite rate control. Anticoagulate with DOAC (apixaban 5 mg BD, rivaroxaban 20 mg OD) if CHA2DS2-VASc ≥2 in men, ≥3 in women. Use HAS-BLED score to assess bleeding risk.
• Hypertension – Diagnosis and Targets: Clinic BP ≥140/90 mmHg; confirm with ambulatory (ABPM) or home monitoring (HBPM). Target clinic BP <140/90 mmHg (<130/80 if CKD, diabetes, or CVD). First-line: ACE inhibitor or ARB if age <55; calcium channel blocker (amlodipine 5 mg) if ≥55 or Black African/Caribbean. Add thiazide-like diuretic (indapamide) if needed.
• Aortic Stenosis – Key Features and Management: Classic triad: angina, syncope, exertional dyspnoea. On examination: slow-rising pulse, narrow pulse pressure, ejection systolic murmur radiating to carotids. Echocardiography: aortic valve area <1.0 cm², mean gradient >40 mmHg, peak jet velocity >4 m/s. Severe symptomatic AS: urgent surgical AVR or TAVI. Avoid vasodilators (e.g., ACE inhibitors) in severe AS.
• Pulmonary Embolism – Diagnosis and Treatment: Use Wells' score; if >4, do D-dimer. If D-dimer positive, CT pulmonary angiogram (CTPA). For haemodynamically stable PE: start rivaroxaban 15 mg BD for 21 days then 20 mg OD, or apixaban 10 mg BD for 7 days then 5 mg BD. For massive PE with shock: IV unfractionated heparin + consider thrombolysis (alteplase 100 mg IV over 2 hours).
• Pericarditis – Diagnosis and Management: Diagnosis: pleuritic chest pain relieved by leaning forward, widespread ST elevation (concave upward) on ECG, pericardial rub. First-line: ibuprofen 600 mg TDS or aspirin 750-1000 mg TDS for 2 weeks, plus colchicine 500 mcg BD (reduce risk of recurrence). Avoid anticoagulants if possible. Consider NSAID + PPI cover.
• Cardiogenic Shock – Recognition and Immediate Steps: Systolic BP <90 mmHg for >30 min despite adequate filling, with end-organ hypoperfusion (cold peripheries, oliguria, confusion). Common causes: massive MI, acute mitral regurgitation, ventricular septal rupture. Immediate: IV dobutamine 5-20 mcg/kg/min or noradrenaline 0.1-0.5 mcg/kg/min. Urgent echocardiogram. Consider intra-aortic balloon pump (IABP) or percutaneous LVAD.

Common Traps in Clinical Problem Solving (CPS) - CVS Questions

• Giving beta-blockers in acute decompensated heart failure with pulmonary oedema – they reduce cardiac output acutely; start only when euvolaemic.
• Using digoxin as first-line rate control in atrial fibrillation without heart failure – beta-blockers or rate-limiting CCBs are preferred.
• Ordering a D-dimer in a patient with high Wells' score (e.g., >6) – do CTPA directly, as D-dimer will be positive and wastes time.
• Prescribing verapamil in heart failure with reduced ejection fraction – it is negatively inotropic and contraindicated.
• Starting anticoagulation in atrial fibrillation without checking bleeding risk (HAS-BLED) or ensuring no contraindications like active peptic ulcer.
• Treating hypertensive urgency (BP >180/120 without end-organ damage) with IV antihypertensives – oral therapy and reassurance is appropriate.

How to Revise Clinical Problem Solving (CPS) - CVS for the MSRA

For CPS-CVS on the MSRA, prioritise acute management algorithms (ACS, PE, acute HF, cardiac arrest) and safe prescribing in chronic conditions (AF, hypertension, chronic HF). Questions are framed as 'choose the next best step' or 'which is the most appropriate initial management?', often with a single best answer. Practise interpreting basic ECGs (STEMI, AF, pericarditis, LVH) and applying risk scores (GRACE, CHA2DS2-VASc, Wells). Avoid over-investigating low-risk presentations (e.g., young patient with atypical chest pain and normal ECG – consider musculoskeletal cause). Focus on NICE and ESC guideline-based first-line treatments, and know common drug doses and contraindications. Use question banks that mimic the MSRA's time pressure and style.

Practise it: MedLumen has 50 Clinical Problem Solving (CPS) - CVS questions for the MSRA, each with a full explanation and references.